|
Market Closed -
Canadian Securities Exchange
09:30:00 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | +100.00% |
|
0.00% | -83.33% |
| Market Cap | 1.19M 844K 741K 700K 638K 80.94M 1.2M 8.37M 3.24M 41.35M 3.17M 3.1M 133M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 470K 333K 292K 276K 251K 31.89M 474K 3.3M 1.28M 16.29M 1.25M 1.22M 52.36M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +100.00% | ||
| Current month | +100.00% | ||
| 1 month | +100.00% | ||
| 3 months | -33.33% | ||
| 6 months | -33.33% | ||
| Current year | -83.33% |
| 1 month | 0 | 0.01 | |
| Current year | 0 | 0.05 | |
| 1 year | 0 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 0.6 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 2019-09-30 |
José Roldan
DFI | Director of Finance/CFO | - | 2022-12-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 2019-09-30 |
Daniel Augereau
BRD | Director/Board Member | 82 | 2019-09-30 |
Eric Klein
BRD | Director/Board Member | 66 | 2019-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/2/25 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 3/21/25 | Buy | Chief Executive Officer | 200,000 | 0.1675% | ||
| 3/21/25 | Buy | Chief Executive Officer | 100,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +100.00% | 0.00% | 0.00% | -90.00% | 844K | ||
| +0.13% | +2.65% | +63.34% | +115.27% | 1,055B | ||
| +0.20% | +0.46% | +50.92% | +72.63% | 654B | ||
| -0.29% | +0.14% | +19.82% | +72.62% | 467B | ||
| -0.85% | +0.98% | +42.13% | +42.98% | 348B | ||
| +0.71% | +4.08% | +21.75% | +29.57% | 275B | ||
| +1.23% | +0.42% | +14.11% | +12.90% | 258B | ||
| +2.11% | +7.51% | +51.88% | +54.14% | 224B | ||
| +0.83% | +0.55% | +34.64% | +99.77% | 187B | ||
| 0.00% | -10.14% | -27.40% | -60.93% | 171B | ||
| Average | +10.41% | +0.67% | +27.12% | +34.90% | 363.83B | |
| Weighted average by Cap. | +0.27% | +1.32% | +40.43% | +68.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.07M 2.69M 2.55M 2.32M 294M 4.37M 30.46M 11.8M 150M 11.53M 11.28M 483M | 3.36M 2.38M 2.09M 1.97M 1.8M 228M 3.38M 23.57M 9.13M 116M 8.92M 8.73M 374M |
| Net income | -16.5M -11.67M -10.24M -9.67M -8.82M -1.12B -16.62M -116M -44.83M -572M -43.82M -42.88M -1.84B | -8.91M -6.3M -5.53M -5.22M -4.76M -604M -8.97M -62.5M -24.21M -309M -23.66M -23.15M -992M |
| Net Debt | -626K -443K -388K -367K -334K -42.42M -630K -4.39M -1.7M -21.67M -1.66M -1.63M -69.65M | -723K -512K -449K -424K -386K -49.05M -729K -5.08M -1.97M -25.06M -1.92M -1.88M -80.53M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















